Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
SCAI pushes back on unpopular policy | Cardiologist disciplined | Procedure kits recalled | The power of quality improvement
Thursday, September 10, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Interventional Cardiology

SCAI asks ABIM to rethink policy on PCI volume reporting requirements

Procedural volume reporting requirements for PCI are no longer necessary, according to SCAI and its members. Those requirements made sense when PCI was new, but that was many years ago. 

READ MORE >
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
Share on Twitter Share on Facebook Share on Linkedin

SCAI asks ABIM to rethink policy on PCI volume reporting requirements

Share on Twitter Share on Facebook Share on Linkedin
Simpsons Interventions, a California-based healthcare technology company, has received the FDA’s breakthrough device designation for its Acolyte Image Guided Crossing and Re-Entry Catheter System. SCAI released the list of its late-breaking clinical study trials at its 2022 annual meeting. #SCAI #SCAI22 #SCAI2022
Procedural volume reporting requirements for PCI are no longer necessary, according to SCAI and its members. Those requirements made sense when PCI was new, but that was many years ago. 
READ MORE >

Texas cardiologist disciplined after allegedly leaving guidewire in patient

According to the Texas Medical Board, the doctor erroneously relied on a radiologist to review follow-up imaging results instead of viewing them on his own.

READ MORE >
artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Texas cardiologist disciplined after allegedly leaving guidewire in patient

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI in healthcare
According to the Texas Medical Board, the doctor erroneously relied on a radiologist to review follow-up imaging results instead of viewing them on his own.
READ MORE >

Cath lab procedure kits recalled due to ongoing safety concern

The manifolds inside these kits have been linked to a significant risk of contamination.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Cath lab procedure kits recalled due to ongoing safety concern

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The manifolds inside these kits have been linked to a significant risk of contamination.
READ MORE >

Catheter-directed thrombolysis significantly improves PE outcomes

New late-breaking data presented at ESC Congress 2026 adds to the growing evidence that more invasive catheter-based pulmonary embolism procedures can improve patient outcomes.

READ MORE >
Deep learning spectral pulmonary embolism (PE) imaging displayed by Canon CT at RSNA.
Share on Twitter Share on Facebook Share on Linkedin

Catheter-directed thrombolysis significantly improves PE outcomes

Share on Twitter Share on Facebook Share on Linkedin
Deep learning spectral pulmonary embolism (PE) imaging displayed by Canon CT at RSNA.
New late-breaking data presented at ESC Congress 2026 adds to the growing evidence that more invasive catheter-based pulmonary embolism procedures can improve patient outcomes.
READ MORE >

FDA announces recall of all Impella heart pump controllers after 3 deaths

Johnson & Johnson MedTech is recalling all of its Automated Impella Controllers due to an ongoing safety issue linked to 37 serious injuries. Care teams can still use these devices as they await a replacement. 

READ MORE >
Johnson & Johnson MedTech Automated Impella Controller
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of all Impella heart pump controllers after 3 deaths

Share on Twitter Share on Facebook Share on Linkedin
Johnson & Johnson MedTech Automated Impella Controller
Johnson & Johnson MedTech is recalling all of its Automated Impella Controllers due to an ongoing safety issue linked to 37 serious injuries. Care teams can still use these devices as they await a replacement. 
READ MORE >

Tricuspid valve repair linked to major benefits for high-risk heart patients

While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.

READ MORE >
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
Share on Twitter Share on Facebook Share on Linkedin

Tricuspid valve repair linked to major benefits for high-risk heart patients

Share on Twitter Share on Facebook Share on Linkedin
An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.
While T-TEER is already known to improve a patient's quality of life, this late-breaking study from ESC Congress 2026 confirmed it also improves survival and reduces the risk of heart failure hospitalization.
READ MORE >

The power of quality improvement: How a cath lab transformed care for PCI patients

A multidisciplinary committee formed in 2022 to identify ways to improve safety and efficiency in their facility's cath lab. By 2024, it was clear the group's proposals had made a major impact.

READ MORE >
quality improvement
Share on Twitter Share on Facebook Share on Linkedin

The power of quality improvement: How a cath lab transformed care for PCI patients

Share on Twitter Share on Facebook Share on Linkedin
quality improvement
A multidisciplinary committee formed in 2022 to identify ways to improve safety and efficiency in their facility's cath lab. By 2024, it was clear the group's proposals had made a major impact.
READ MORE >

No significant sex-based differences in timing of care for M-TEER patients

Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

No significant sex-based differences in timing of care for M-TEER patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Previous studies over the years have suggested women with severe mitral regurgitation face longer delays in care than men. This latest analysis suggests multidisciplinary care teams are helping put an end to that trend.
READ MORE >

OCT shows potential for image-guided BTK interventions in PAD patients

OCT and IVUS appear to be comparable when assessing patients with chronic limb-threatening ischemia. OCT offers a clearer look at the patient's calcium, however, and researchers are hoping to learn just how much value that improved clarity may provide.

READ MORE >
Examples of OCT (left) and IVUS (right) images of two different subjects with calcium. Blue arrows denote calcium noted on OCT, red asterisks mark calcium on IVUS
Share on Twitter Share on Facebook Share on Linkedin

OCT shows potential for image-guided BTK interventions in PAD patients

Share on Twitter Share on Facebook Share on Linkedin
Examples of OCT (left) and IVUS (right) images of two different subjects with calcium. Blue arrows denote calcium noted on OCT, red asterisks mark calcium on IVUS
OCT and IVUS appear to be comparable when assessing patients with chronic limb-threatening ischemia. OCT offers a clearer look at the patient's calcium, however, and researchers are hoping to learn just how much value that improved clarity may provide.
READ MORE >

Veteran interventional cardiologist named editor-in-chief of ACC journal

Mohamad Alkhouli, MD, MBA, a professor of medicine at Mayo Clinic School of Medicine and practicing cardiologist, has been named the next editor-in-chief of JACC: Cardiovascular Interventions.

READ MORE >
Mohamad Alkhouli, MD, MBA
Share on Twitter Share on Facebook Share on Linkedin

Veteran interventional cardiologist named editor-in-chief of ACC journal

Share on Twitter Share on Facebook Share on Linkedin
Mohamad Alkhouli, MD, MBA
Mohamad Alkhouli, MD, MBA, a professor of medicine at Mayo Clinic School of Medicine and practicing cardiologist, has been named the next editor-in-chief of JACC: Cardiovascular Interventions.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup